197 related articles for article (PubMed ID: 16164672)
1. Combination renin-angiotensin system blockade in hypertension.
Doulton TW; Macgregor GA
Kidney Int; 2005 Oct; 68(4):1898. PubMed ID: 16164672
[No Abstract] [Full Text] [Related]
2. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
3. Dual renin-angiotensin system blockade: on the target.
Robles NR
Int J Clin Pract; 2008 Aug; 62(8):1134-6. PubMed ID: 18705817
[No Abstract] [Full Text] [Related]
4. Dual blockade of renin-angiotensin system in primary focal segmental glomerulosclerosis.
Singh A
Nephrol Dial Transplant; 2006 Mar; 21(3):830-1. PubMed ID: 16278255
[No Abstract] [Full Text] [Related]
5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
6. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
Hollenberg NK
Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of RAAS inhibition in patients on peritoneal dialysis.
Guest S
Nephrol News Issues; 2012 May; 26(6):42-5. PubMed ID: 22690459
[No Abstract] [Full Text] [Related]
8. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
9. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibition: what are the clinical perspectives?
Hollenberg NK
Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787
[TBL] [Abstract][Full Text] [Related]
11. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
12. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Weber MA
Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
[TBL] [Abstract][Full Text] [Related]
13. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
14. [Debate concerning the optimal blockage of the renin-angiotensin system].
Choukroun G
Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
[No Abstract] [Full Text] [Related]
15. Dual renin-angiotensin system blockade in heart failure.
McMurray JJ; Granger CB; Ostergren J; Yusuf S; Pfeffer MA; Swedberg K
J Am Coll Cardiol; 2009 Jul; 54(3):278; author reply 279-80. PubMed ID: 19589444
[No Abstract] [Full Text] [Related]
16. [High risk arterial hypertension: the role of angiotensin II receptor blockers].
Fomin VV; Moiseev SV; Mukhin NA
Ter Arkh; 2007; 79(10):86-91. PubMed ID: 18154154
[No Abstract] [Full Text] [Related]
17. Dual renin-angiotensin system blockade and kidney disease.
Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Pfeffer MA
J Am Coll Cardiol; 2009 Jul; 54(3):278-9; author reply 279-80. PubMed ID: 19589445
[No Abstract] [Full Text] [Related]
18. Anti-diabetic effect of blockade of the renin-angiotensin system.
Ando K; Fujita T
Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
[TBL] [Abstract][Full Text] [Related]
19. Rationale for combining blockers of the renin-angiotensin system.
Azizi M; Wuerzner G
Semin Nephrol; 2007 Sep; 27(5):544-54. PubMed ID: 17868792
[TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
Schindler C; Kosa M; Schröder J; Kirch W
Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
